series-a
Stage
2018
Founded
1
Investors
About
A biotechnology company developing novel small molecule therapies directed against novel therapeutic targets in oncology, including proteins that regulate RNA.
Explore 858 Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.